Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04134728
Brief Title: Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors

First Submitted : October 18, 2019
First Submitted that Met QC Criteria : October 18, 2019
First Posted : October 22, 2019

Last Update Submitted that Met QC Criteria : November 14, 2019
Last Update Posted : November 18, 2019